Conclusions
In conclusion, the test ezetimibe tablets developed by Chongqing shenghuaxi Pharmaceutical Co., Ltd. are equivalent to the Ezetrol® produced by MSD Pharma (Singapore) Pte. Ltd. The results confirmed the PK of ezetimibe tablets to be similar to that of the Ezetrol® after a single dose of 10 mg in healthy chinese participants. The trial proved that ezetimibe tablets and Ezetrol® were bioequivalent under both fasted condition and fed condition. The ezetimibe tablets can be used in the treatment of exogenous cholesterol absorption in the patients.